Related Experiment Videos
Ischemic acute renal failure: an inflammatory disease?
1Medical Services, Brigham and Women's Hospital and Department of Medicine, Harvard Medical School, and Harvard-Massachusetts Institute of Technology, Division of Health Sciences and Technology, Charlestown, USA. joseph_bonventre@hms.harvard.edu
Kidney International
|July 16, 2004
Summary
Inflammation drives acute kidney injury from ischemia. Understanding leukocyte, endothelial, and epithelial cell roles in this inflammatory response may reveal new therapeutic targets for kidney protection.
Area of Science:
- Nephrology
- Immunology
- Pathophysiology
Background:
- Inflammation is central to acute kidney injury (AKI) pathophysiology following ischemic events.
- Endothelial cells, epithelial cells, and leukocytes are key players in the renal inflammatory response.
- Cytokines and chemokines significantly influence both the injury and recovery phases of AKI.
Purpose of the Study:
- To review the contribution of cellular components and mediators to inflammation in ischemic AKI.
- To explore protective mechanisms in the mouse kidney, such as preconditioning, as models for therapeutic development.
- To identify molecular targets for therapeutic intervention by understanding the inflammatory cascade in AKI.
Main Methods:
- Review of existing literature on inflammation in ischemic acute kidney injury.
- Analysis of the roles of specific cell types (endothelial, epithelial, leukocytes) in the inflammatory process.
- Examination of cytokine and chemokine involvement during injury and recovery phases.
Main Results:
- Inflammatory cells and mediators are critical in the development and resolution of ischemic AKI.
- Preconditioning models in mice demonstrate kidney resilience, offering insights into protective strategies.
- Specific molecular pathways involved in the inflammatory response have been identified.
Conclusions:
- Targeting the inflammatory response is crucial for developing therapies for ischemic AKI.
- Understanding cellular and molecular mechanisms of kidney inflammation can guide the discovery of protective agents.
- Mouse models of kidney preconditioning provide valuable frameworks for pharmacological research in AKI.